Bayer news

• 12 May 2025

  Bayer refocuses Crop Science R&D and production in Germany on strategic technologies

  Production in Frankfurt ends by 2028; R&D moves to Monheim. Dormagen streamlines, focusing on innovation. Job impacts addressed with employee reps.
• 

  4 April 2025

  Bayer and Iberdrola España to Electrify and Decarbonize Asturias Plant

  The project uses renewable energy for steam production, reducing CO2 emissions and enhancing industrial competitiveness, with completion expected by June 2026.
• 

  13 February 2024

  PanTera and Bayer Sign Actinium-225 Supply Agreement

  Starting in late 2024, PanTera will supply actinium-225, enhancing access for clinical trials and developing a large-scale production facility to meet global demand for radiopharma-based cancer treatments.
• 

  30 August 2023

  Bayer invests EUR 220 million in Monheim R&D facility

  The new facility will focus on developing sustainable crop protection solutions, enhancing safety, and leveraging AI, with completion expected by 2026.
• 

  9 November 2021

  Bayer to Start Nifedipine Production in Asturias

  The Asturias plant will produce Nifedipine, moving production from Germany. The new line, approved in February, will be operational by end of 2021, with key officials attending the commissioning.
• 

  16 January 2020

  WuXi Biologics Acquires Bayer's Drug Plant in Germany

  The plant will serve as a back-up site for Kovaltry™ production. The deal includes equipment purchase and a long-term lease. Financial details undisclosed.

• 

  29 May 2015

  Bayer's New CO2-Based Plastics Line in Dormagen

  A new production line in Germany will use CO2 to produce polyols for polyurethane foam. The plant aims for 5,000 metric tons annually, reducing reliance on petroleum and advancing sustainable materials.
• 

  9 December 2014

  Bayer Completes Major Investment in Germany

  A new TDI plant in Dormagen, costing EUR 250 million, boosts production efficiency and job security, while enhancing North Rhine-Westphalia's competitiveness in the chemical industry.
• 

  22 November 2013

  Bayer MaterialScience Boosts Technology and Production

  Investing over EUR 45 million, the company enhances its technical center and builds a new plant to meet rising demand in automotive, construction, and coating markets, ensuring efficient, sustainable production.
• 

  28 March 2013

  CropScience and Syngenta Propose Plan to Address EU Bee Health Stalemate

  The plan includes enhancing pollinator habitats, comprehensive bee health monitoring, strict exposure mitigation measures, reducing dust emissions, and investing in research on bee health factors.
• 

  14 March 2011

  Bayer to Invest €100M in German MDI Plant Expansion

  The investment will expand MDI production at Brunsbüttel, enhancing capacity and job security. The project includes new plants and uses advanced, energy-efficient technologies.
• 

  1 March 2010

  Bayer MaterialScience to Build New TDI Plant in Dormagen

  The new TDI plant in Dormagen will cost EUR 150 million, have a 300,000-ton capacity, and use innovative, energy-efficient technology. It aims to enhance regional competitiveness and job security.
• 

  29 January 2010

  Bayer Opens Largest Carbon Nanotube Pilot Facility

  The new facility in Leverkusen produces 200 metric tons of carbon nanotubes annually, aiming to meet growing demand and create jobs. Baytubes® enhance materials' strength and electrical properties.
• 

  1 January 1999

  Linde Builds Bayer Monoethylene Glycol Plant

  Location: EC Erdölchemie GmbH, Cologne. Capacity: 150 kt/a monoethylene glycol, 20 kt/a diethylene glycol, 2.5 kt/a triethylene glycol. Scope: Licensing, engineering, procurement, supervision. Start-up: 1999.